Para IV Winners and Losers - October 2018
This month’s Para IV developments suggest that there can be benefit for Amneal Pharmaceuticals Inc (AMRX US) in Xyren and Faslodex, Wockhardt Ltd...
431 Views
Year-End Resolution Seen for Akorn/Fresenius Case
A post-trial briefing schedule for the Akorn/Fresenius case was set July 16 that would suggest a final legal resolution of the case around...
282 Views
Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure
Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...
528 Views
NxStage/Fresenius FTC Review Could Be Helped by Recent CVS Announcement
On April 4, CVS Health announced a new initiative focused on chronic kidney disease with a planned introduction of “a truly innovative new home...
156 Views
AI & Machine Learning Disrupting The Healthcare Industry
In the omnipresence of machine learning, one of the most impacted segments is healthcare. Not only is AI in healthcare at the forefront of a...
600 Views